Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare stocks to buy. On January 26, UBS lifted the price target on Gilead Sciences, Inc. (NASDAQ:GILD) from $145 to $155 and ...

Emily Field, head of European pharma research at Barclays, discusses which drug makers would be most impacted by 30% U.S. tariffs on EU imports, and the likelihood President Trump moves ahead with up ...

Indian Council of Medical Research (ICMR) Director General Rajiv Bahl noted that the government has initiated a significant ...

The so-called “mother of all deals” lowers import tariffs on European pharma exports from 11% to zero and also eliminates ...

In my followup on Takeda Pharmaceutical Co (TAK), I am reaffirming my buy rating from March. Clinical demand in multiple areas, along with an active drug pipeline, could keep driving the top-line ...

India’s pharmaceutical sector has come under significant pressure in 2025, with the Nifty Pharma index falling more than 6 percent during the first half of the year. In stark contrast, the broader ...

Our Bureau, Bengaluru Wednesday, February 4, 2026, 12:40 Hrs [IST] ...

The Indian pharmaceutical industry is the world’s third-largest by volume, meeting approximately 20% of global generics demand ...

Lucknow: UP offers some of the most competitive policies and incentives in the country for pharmaceutical investments, said industrial development, export promotion and investment minister Nand Gopal ...

As India prepares for Budget 2026, the pharmaceutical sector seeks to transition from production to innovation, advocating for increased public healthcare investment and diversified exports to boost ...

Affordable medicine and a skilled workforce are the backbone of growth. But with the pharma industry under strain, both are now at risk, threatening Bangladesh’s economic momentum ...

Nigeria's pharmaceutical sector is recording growing investor interest and commitments, but local manufacturing continues to lag, ...